Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial-Reference-Cited by-同舟云学术

Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial

Published:2019-05 Issue:5 Volume:11 Page:1788-1798
ISSN:2072-1439
Container-title:Journal of Thoracic Disease
language:
Short-container-title:J. Thorac. Dis.

Author:

Kleontas Athanasios,Sioga Antonia,Pandria Niki,Barbetakis Nikolaos,Lazopoulos Achilleas,Katsikas Ioannis,Asteriou Christos,Paliouras Dimitrios,Kamperis Efstathios,Ikonomou Dimitrios,Papamitsou Theodora,Filippou Dimitrios,Destouni Chariklia,Ikonomou Louiza,Zarogoulidis Konstantinos,Papagiannopoulos Kostas

Publisher

AME Publishing Company

Subject

Pulmonary and Respiratory Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant pleural disease;Breathe;2023-12

2. Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion;Scientific Reports;2023-07-26

3. Hyperthermic intrathoracic extracorporeal chemotherapy for secondary malignant pleural disease;Journal of Surgical Oncology;2023-07-06

4. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?;Seminars in Respiratory and Critical Care Medicine;2023-06-12

5. A Meta-Analysis of the Clinical Efficacy of Hyperthermic Intrathoracic Chemotherapy in the Treatment of Malignant Pleural Effusion Caused by Lung Cancer;Advances in Clinical Medicine;2023